Literature DB >> 32719224

Occult drug resistance in tuberculosis: Emerging issues, upcoming challenges & possible solutions.

Baijayantimala Mishra1, Prasanta Raghab Mohapatra2.   

Abstract

Entities:  

Year:  2020        PMID： 32719224      PMCID： PMC7602933          DOI： 10.4103/ijmr.IJMR_316_19

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  14 in total

1.  Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study.

Authors:  Ndivhuho A Makhado; Edith Matabane; Mauro Faccin; Claire Pinçon; Agathe Jouet; Fairouz Boutachkourt; Léonie Goeminne; Cyril Gaudin; Gugu Maphalala; Patrick Beckert; Stefan Niemann; Jean-Charles Delvenne; Michel Delmée; Lufuno Razwiedani; Maphoshane Nchabeleng; Philip Supply; Bouke C de Jong; Emmanuel André
Journal:  Lancet Infect Dis       Date:  2018-10-18       Impact factor: 25.071

2.  The Coming of Age of Drug-Susceptibility Testing for Tuberculosis.

Authors:  Helen Cox; Valerie Mizrahi
Journal:  N Engl J Med       Date:  2018-09-26       Impact factor: 91.245

3.  Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.

Authors:  T Agizew; R Boyd; A F Auld; L Payton; S L Pals; P Lekone; V Chihota; A Finlay
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

Review 4.  Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.

Authors:  Myo T Zaw; Nor A Emran; Zaw Lin
Journal:  J Infect Public Health       Date:  2018-04-26       Impact factor: 3.718

5.  Molecular characteristics of rifampin- and isoniazid-resistant mycobacterium tuberculosis strains isolated in Vietnam.

Authors:  Nghiem Ngoc Minh; Nguyen Van Bac; Nguyen Thai Son; Vu Thi Kim Lien; Chu Hoang Ha; Nguyen Huu Cuong; Cung Thi Ngoc Mai; Thanh Hoa Le
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

6.  Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis.

Authors:  Gilman Kit Hang Siu; Ying Zhang; Terrence C K Lau; Ricky W T Lau; Pak-Leung Ho; Wing-Wai Yew; Stephen K W Tsui; Vincent C C Cheng; Kwok-Yung Yuen; Wing-Cheong Yam
Journal:  J Antimicrob Chemother       Date:  2011-01-17       Impact factor: 5.790

7.  Direct detection of rifampin-resistant mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing.

Authors:  W C Yam; C M Tam; C C Leung; H L Tong; K H Chan; E T Y Leung; K C Wong; W W Yew; W H Seto; K Y Yuen; P L Ho
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality.

Authors:  Madhukar Pai; Soumyadeep Bhaumik; Soumitra S Bhuyan
Journal:  BMJ Glob Health       Date:  2017-03-20

9.  Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.

Authors:  Paola M V Rancoita; Federica Cugnata; Ana Luíza Gibertoni Cruz; Philip W Fowler; Daniela M Cirillo; Emanuele Borroni; Sarah J Hoosdally; Timothy M Walker; Clara Grazian; Timothy J Davies; Timothy E A Peto; Derrick W Crook
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

10.  Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.

Authors:  Gian Luca Di Tanna; Ali Raza Khaki; Grant Theron; Kerrigan McCarthy; Helen Cox; Lucy Mupfumi; Anete Trajman; Lynn Sodai Zijenah; Peter Mason; Tsitsi Bandason; Betina Durovni; Wilbert Bara; Michael Hoelscher; Petra Clowes; Chacha Mangu; Duncan Chanda; Alexander Pym; Peter Mwaba; Frank Cobelens; Mark P Nicol; Keertan Dheda; Gavin Churchyard; Katherine Fielding; John Z Metcalfe
Journal:  Lancet Glob Health       Date:  2019-02       Impact factor: 26.763
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.